Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1115418 BOSTON, MA
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$222,457
+$27,647 QoQ
Shares Held
17,434
+23.1% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 103 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. TNXP ranks #235 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in TNXP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $222,457 17,434
2026-03-31 $194,810 14,168
2025-12-31 $198,920 12,735
2025-09-30 $294,896 12,206
2025-06-30 $406,502 11,298
2025-03-31 $244,419 13,670
2022-03-31 $86,013 373,973
2021-12-31 $129,659 360,166
2021-09-30 $201,768 336,281
2021-06-30 $357,629 322,189